About Fujirebio

More than 50 years' experience in pioneering IVD testing solutions 

We are a global leader in the field of high quality in vitro diagnostics (IVD) testing. At Fujirebio (our name is pronounced Fuji-Ray-Bee-o and symbolizes restoration of health) we have more than 50 years’ accumulated experience in the discovery, development, manufacturing and worldwide commercialization of robust IVD products.

Historically based in Japan with the country’s deeply rooted culture of excellence Fujirebio has over the years been shaped by the successful integration of pioneering and experienced international IVD players such as Centocor Diagnostics in 1998, CanAg Diagnostics in 2006 and Innogenetics in 2010. Our global presence includes offices in the United States, Europe, Latin America and Asia as well as a vast international distribution network.

Our IVD product lines span from specialized manual testing to fully automated routine clinical laboratory testing solutions and include both novel and routine biomarkers. We cover a variety of disease states such as infectious, oncology, genetic testing, thyroid, fertility, tissue typing, neurodegeneration and bone metabolism.

This brief video summarizes our main corporate and product milestones:

We have a strong and long lasting tradition for developing high quality routine and truly novel biomarkers in collaboration with the clinical community worldwide.

Established in 1950 we are today a fully owned subsidiary of Miraca Holdings (listed in the Tokyo Stock Exchange - MRCHF) and employ more than 1.200 people in Asia, Europe and America, including subsidiaries.


We suggest you also read:

> More detailed information is available in the global Fujirebio website
> For more information about Miraca Holdings visit the group website


You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below: